The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, accordi

Award for Prof Piot's work on the worldwide prevention of infectious diseases.

Researchers welcome reassuring findings but note poor quality drugs are still a problem.

Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in

Researchers have found evidence of attempts by the tobacco industry to reinterpret Islamic teaching to make smoking acceptable to Muslims and to help develop markets in countries with large Muslim populations.

Middle-aged people who are underweight (with a Body Mass Index [BMI] less than 20 kg/m2 [1]) are a third more likely to develop dementia than people of similar age with a healthy BMI, ac

A decade on from the Northern Nigeria polio vaccination boycott and its global costs to the polio eradication initiative, a new report examines global issues affecting confidence and hesitation around vaccines since the new millennium.

New research reveals weaknesses in Government?s public-private partnership with alcohol industry.

Parents of obese children may not be able to recognise that their child is overweight unless they are at very extreme levels of obesity, according to new research.

First-of-its-kind analysis identifies forms of disease associated with higher-risk pregnancies.